Emergence of Resistance in HIV-1 Integrase with Dolutegravir Treatment in a Pediatric Population from the IMPAACT P1093 Study is a research paper published in Antimicrobial Agents and Chemotherapy (2021). On theSindex it has a DataRank of 1.9. It has been cited 34 times, with 33 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.533
From this paper's citation signal
Citation Network Contribution
1.4
From 30 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 33 citers.
NICHD NIH HHS
Grant: HHSN275201800001C
NIAID NIH HHS
Grant: UM1 AI068616
NIAID NIH HHS
Grant: UM1 AI069456
NICHD NIH HHS
Grant: HHSN275201800001I
NIAID NIH HHS
Grant: UM1 AI068632
NIAID NIH HHS
Grant: UM1 AI106716
National Institutes of Health
Grant: 5UM1AI106716-07
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Laboratory Center
National Institutes of Health
Grant: 7UM1AI068632-07
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group
National Institutes of Health
Grant: 5UM1AI068616-14
SDMC - IMPAACT Leadership Group
ViiV Healthcare
FWCI
1.55
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals